Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard ...

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the ...

Patients expressed concern that overreliance on artificial intelligence (AI) could lead to clinicians losing their skills, ...

These studies published in The American Journal of Managed Care® explored telehealth, care access, and patient experience ...

An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate ...

The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance ...

A multidisciplinary approach, early diagnosis, and comprehensive caregiver education are crucial in effectively managing ...

Jorge García, PharmD, MS, MBA, MHA, highlights the need for infusion pharmacy optimization to sustain oncology care amid rising costs and evolving value-based reimbursement models.